Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance
- PMID: 17200721
- PMCID: PMC1716196
- DOI: 10.1172/JCI17645
Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance
Abstract
Glucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of beta cell-specific Gck (Gck(+/-)) causes impaired insulin secretion to glucose, although the animals have a normal beta cell mass. When fed a high-fat (HF) diet, wild-type mice showed marked beta cell hyperplasia, whereas Gck(+/-) mice demonstrated decreased beta cell replication and insufficient beta cell hyperplasia despite showing a similar degree of insulin resistance. DNA chip analysis revealed decreased insulin receptor substrate 2 (Irs2) expression in HF diet-fed Gck(+/-) mouse islets compared with wild-type islets. Western blot analyses confirmed upregulated Irs2 expression in the islets of HF diet-fed wild-type mice compared with those fed standard chow and reduced expression in HF diet-fed Gck(+/-) mice compared with those of HF diet-fed wild-type mice. HF diet-fed Irs2(+/-) mice failed to show a sufficient increase in beta cell mass, and overexpression of Irs2 in beta cells of HF diet-fed Gck(+/-) mice partially prevented diabetes by increasing beta cell mass. These results suggest that Gck and Irs2 are critical requirements for beta cell hyperplasia to occur in response to HF diet-induced insulin resistance.
Figures








Comment in
-
A dominant role for glucose in beta cell compensation of insulin resistance.J Clin Invest. 2007 Jan;117(1):81-3. doi: 10.1172/JCI30862. J Clin Invest. 2007. PMID: 17200709 Free PMC article.
Similar articles
-
Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.Diabetes Obes Metab. 2008 Nov;10 Suppl 4:147-56. doi: 10.1111/j.1463-1326.2008.00951.x. Diabetes Obes Metab. 2008. PMID: 18834442
-
Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1694-701. doi: 10.1152/ajpendo.00430.2006. Epub 2007 Feb 13. Am J Physiol Endocrinol Metab. 2007. PMID: 17299086
-
The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice.Metabolism. 2018 Aug;85:48-58. doi: 10.1016/j.metabol.2018.03.010. Epub 2018 Mar 12. Metabolism. 2018. PMID: 29544862
-
Regulating insulin signaling and beta-cell function through IRS proteins.Can J Physiol Pharmacol. 2006 Jul;84(7):725-37. doi: 10.1139/y06-008. Can J Physiol Pharmacol. 2006. PMID: 16998536 Review.
-
[Knockout mouse models for type 2 diabetes. Mice with insulin resistance].Nihon Rinsho. 2002 Aug;60 Suppl 8:64-9. Nihon Rinsho. 2002. PMID: 12355825 Review. Japanese. No abstract available.
Cited by
-
A simple matter of life and death-the trials of postnatal Beta-cell mass regulation.Int J Endocrinol. 2012;2012:516718. doi: 10.1155/2012/516718. Epub 2012 Apr 22. Int J Endocrinol. 2012. PMID: 22577380 Free PMC article.
-
Phogrin Regulates High-Fat Diet-Induced Compensatory Pancreatic β-Cell Growth by Switching Binding Partners.Nutrients. 2024 Jan 4;16(1):169. doi: 10.3390/nu16010169. Nutrients. 2024. PMID: 38201998 Free PMC article.
-
Production of a mouse strain with impaired glucose tolerance by systemic heterozygous knockout of the glucokinase gene and its feasibility as a prediabetes model.Exp Anim. 2015;64(3):231-9. doi: 10.1538/expanim.14-0089. Epub 2015 Mar 10. Exp Anim. 2015. PMID: 25765873 Free PMC article.
-
E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance.Cell Rep. 2022 Oct 4;41(1):111436. doi: 10.1016/j.celrep.2022.111436. Cell Rep. 2022. PMID: 36198264 Free PMC article.
-
HB-EGF Signaling Is Required for Glucose-Induced Pancreatic β-Cell Proliferation in Rats.Diabetes. 2020 Mar;69(3):369-380. doi: 10.2337/db19-0643. Epub 2019 Dec 27. Diabetes. 2020. PMID: 31882563 Free PMC article.
References
-
- Matschinsky F.M., Ellerman J.E. Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 1968;243:2730–2736. - PubMed
-
- Velho G., et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia. 1997;40:217–224. - PubMed
-
- Terauchi Y., et al. Pancreatic β-cell-specific targeted disruption of glucokinase gene. J. Biol. Chem. 1995;270:30253–30256. - PubMed
-
- Matschinsky F.M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 1996;45:223–241. - PubMed
-
- Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 1994;43:735–740. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous